Wells Fargo & Company Lowers Bio-Rad Laboratories (NYSE:BIO) Price Target to $245.00
Bio-Rad Laboratories (NYSE:BIO – Get Free Report) had its target price decreased by analysts at Wells Fargo & Company from $260.00 to $245.00 in a report issued on Monday,Benzinga reports. The firm presently has an “equal weight” rating on the medical research company’s stock. Wells Fargo & Company‘s target price indicates a potential upside of […]
Bio-Rad Laboratories (NYSE:BIO – Get Free Report) had its target price decreased by analysts at Wells Fargo & Company from $260.00 to $245.00 in a report issued on Monday,Benzinga reports. The firm presently has an “equal weight” rating on the medical research company’s stock. Wells Fargo & Company‘s target price indicates a potential upside of […]
